U.S. Clinical Perinatal Software Market Size, Share & Forecast 2026–2032

ID: MR-11468 | Published: November 2026
Download PDF Sample

Report Highlights

  • ✓Country: United States
  • ✓Market: Clinical Perinatal Software Market
  • ✓Market Size 2024: USD 1.42 billion
  • ✓Market Size 2032: USD 2.61 billion
  • ✓CAGR: 7.9%
  • ✓Base Year: 2025
  • ✓Forecast Period: 2026–2032
Market Growth Chart
Want Detailed Insights - Download Sample
Analyst Findings and Recommendations
FINDING 01
Fetal Analytics Commoditising: Philips and GE HealthCare bundle fetal monitoring analytics with hardware, while Epic Systems' native maternal documentation modules are displacing standalone obstetric dashboards in Epic-run hospitals. Vendors selling only fetal heart rate algorithms face margin compression within two years.
FINDING 02
Reimbursement Dictates Demand: Medicaid postpartum extension is not the binding constraint on adoption. Software purchases accelerate only where state Medicaid agencies reimburse remote blood pressure monitoring under CPT 99453 and 99454, so state billing rules, not federal coverage, decide vendor demand.
ANALYST RECOMMENDATION

Analyst Recommendation — Demand Certified FHIR APIs: Buyers should require certified FHIR R4 APIs in every obstetric module contract signed during 2025 and 2026, since CMS-0057-F enforces API compliance from January 1, 2027. Vendors unable to certify by that date should be excluded from shortlists.

Clinical Perinatal Software in the U.S.: Market Overview

The U.S. clinical perinatal software market was valued at USD 1.42 billion in 2024 and is forecast to reach USD 2.61 billion by 2032. It spans electronic fetal monitoring analytics, labor and delivery documentation, neonatal intensive care informatics, and postpartum risk scoring. Market structure is split between large EHR vendors such as Epic Systems and Oracle Health, which bundle obstetric modules, and device-software firms such as GE HealthCare and Philips, which sell monitoring analytics alongside hardware.

Policy has shaped the market's form more than private demand has. The HITECH Act of 2009 and the CMS Medicare and Medicaid EHR Incentive Programs, now administered as Promoting Interoperability, forced hospitals to adopt certified EHRs, creating the documentation backbone that obstetric modules now extend. Private firms led in fetal monitoring analytics and decision support, where Natus Medical and Mindray competed on algorithms long before federal reimbursement recognized them.

Policy-Driven Growth in U.S. Perinatal Software

The American Rescue Plan Act of 2021, Section 9812, gave states the option to extend Medicaid postpartum coverage from 60 days to 12 months, and Medicaid finances roughly 41 percent of U.S. births. Longer coverage extends the billable window for remote blood pressure monitoring and postpartum risk-scoring software, allowing vendors to bill recurring subscriptions rather than one-time implementations. The CMS Transforming Maternal Health (TMaH) Model, launched in January 2024, channels funding to selected state participants to deploy maternal care technology, converting coverage policy into procurement budgets.

The Preventing Maternal Deaths Act of 2018 (Public Law 115-344) reauthorized state maternal mortality review committees and encouraged structured severe maternal morbidity data capture, pushing hospitals to add standardized obstetric fields to EHR workflows. The ONC HTI-1 Final Rule, published December 2023, requires certified health IT developers to disclose source attributes for predictive decision support interventions under 45 CFR Part 170, with compliance phased in from January 1, 2025. This transparency mandate rewards vendors with certified obstetric risk-scoring tools, because hospital buyers now demand documented provenance before deployment.

Regulatory Barriers and Compliance Costs for U.S. Perinatal Software

FDA's Center for Devices and Radiological Health regulates perinatal software that analyzes fetal heart rate or predicts obstetric deterioration as a medical device under the Federal Food, Drug, and Cosmetic Act. Most such products require 510(k) clearance, and the MDUFA V performance goal sets a 90 FDA-day review target, but elapsed time including deficiency responses typically extends to six to twelve months. The Quality Management System Regulation under 21 CFR Part 820, aligned with ISO 13485:2016, takes effect February 2, 2026, requiring vendors to re-document design controls and supplier management before that date.

The HHS Office of the National Coordinator, now within the Assistant Secretary for Technology Policy, enforces information blocking provisions created by Section 4004 of the 21st Century Cures Act. Developers face civil monetary penalties of up to USD 1 million per violation, and an interface that restricts clinicians' access to a patient's labor record can trigger enforcement. Vendors must also meet ONC Health IT certification criteria under 45 CFR Part 170 and HIPAA Security Rule requirements administered by the HHS Office for Civil Rights, adding audit and encryption costs to every hospital deployment.

Opportunities Created by Policy in U.S. Perinatal Software

The TMaH Model creates a procurement pathway for state-funded maternal software, particularly remote patient monitoring tools billed under CPT codes 99453, 99454, and 99457 for device setup, data transmission, and clinical management. Vendors that package these codes with postpartum hypertension alerts gain reimbursable value inside Medicaid managed care contracts. Opportunity concentrates in states that have adopted the 12-month postpartum extension, because those programs supply the continuous coverage needed to support subscription pricing.

CMS-0057-F, the Interoperability and Prior Authorization Final Rule, requires impacted payers to implement HL7 FHIR APIs from January 1, 2027, opening demand for FHIR-native obstetric modules that exchange data with payer systems. HTI-1 transparency requirements create a second opening, since hospitals procuring predictive labor-risk tools need certified products with documented training data. Vendors that package these attributes into certified modules capture share from non-certified competitors that cannot clear hospital governance reviews.

Market at a Glance

MetricValue
Market Size 2024USD 1.42 billion
Market Size 2032USD 2.61 billion
Growth Rate (CAGR)7.9%
Most Critical Decision FactorFDA clearance and FHIR interoperability compliance readiness
Largest RegionSouth Census Region
Competitive StructureConcentrated among EHR platforms and device incumbents, with fragmented specialist vendors

Leading Market Participants

  • GE HealthCare
  • Philips
  • Epic Systems
  • Oracle Health
  • Natus Medical
  • Mindray
  • Hologic
  • Masimo
  • Medtronic
  • Dräger

Regulatory and Policy Environment for U.S. Perinatal Software

The primary legislation is the Federal Food, Drug, and Cosmetic Act, with software functions governed by FDA guidance including Clinical Decision Support Software (September 2022) and final guidance on Predetermined Change Control Plans for AI-enabled device software functions (December 2024). Interoperability and information blocking fall under Section 4004 of the 21st Century Cures Act, implemented through 45 CFR Parts 170 and 171. Key compliance requirements include FDA 510(k) clearance, QMSR conformance from February 2, 2026, certified FHIR APIs under CMS-0057-F from January 1, 2027, and HIPAA Security Rule compliance, administered by FDA CDRH, ASTP/ONC, CMS, and HHS OCR.

Compared with regional peers, the U.S. relies on a product-based premarket clearance route, whereas the EU Medical Device Regulation (EU) 2017/745 classifies standalone software under Rule 11 and requires notified body certification. The EU Artificial Intelligence Act, Regulation (EU) 2024/1689, imposes high-risk obligations on medical AI from August 2027, a deadline without an equivalent U.S. statutory counterpart. Health Canada applies a risk-based licensing regime for software as a medical device, which is less prescriptive on interoperability than CMS-0057-F.

Long-Term Policy Outlook for U.S. Perinatal Software

By 2032, the policy environment will tighten around AI-enabled obstetric tools, with FDA extending PCCP-based oversight to adaptive algorithms used in labor monitoring and postpartum risk scoring. Congress is expected to decide whether the Medicaid 12-month postpartum option becomes a permanent national standard, a decision that would lift subscription revenue across all states. Continued CMS funding for TMaH-style state models will sustain procurement demand through the forecast period.

These changes will reshape the market toward platform consolidation, as EHR vendors such as Epic Systems and Oracle Health absorb standalone obstetric analytics through certified APIs. Standalone fetal monitoring vendors lacking FHIR-native architecture and PCCP documentation will lose hospital contracts to bundled offerings. Reimbursement pressure from CMS remote monitoring codes will make per-patient analytics pricing the dominant commercial model by 2032.

Frequently Asked Questions

Most fetal heart rate analysis software is cleared through 510(k) premarket notification under 21 CFR Part 807. Novel algorithms without a predicate device can require De Novo classification, which adds months to market entry.
Section 4004 of the 21st Century Cures Act prohibits practices that interfere with access to electronic health information, and ASTP/ONC enforces it. Developers face civil monetary penalties of up to USD 1 million per violation.
CMS-0057-F is the Interoperability and Prior Authorization Final Rule, requiring impacted payers to implement HL7 FHIR APIs. Compliance begins January 1, 2027.
No, ARPA Section 9812 gave states an option, and each state adopts it through a state plan amendment. Adoption status determines the billable coverage window available to software vendors in that state.
Vendors placing AI systems on the EU market must comply with Regulation (EU) 2024/1689 regardless of their U.S. location. High-risk obligations for medical AI apply from August 2027.

Market Segmentation

By Deployment Model
  • Cloud-Based
  • On-Premise
  • Hybrid
  • Software as a Service
By Application
  • Fetal Monitoring Analytics
  • Labor and Delivery Documentation
  • Neonatal Care Informatics
  • Postpartum Risk Monitoring
By End User
  • Hospitals
  • Ambulatory Birth Centers
  • Maternity Clinics
  • Medicaid Managed Care Plans

Table of Contents

Chapter 01 Methodology and Scope
1.1 Research Methodology
1.2 Scope and Definitions
1.3 Data Sources
Chapter 02 Executive Summary
2.1 Report Highlights
2.2 Market Size and Forecast 2024-2032
Chapter 03 U.S. Clinical Perinatal Software - Market Analysis
3.1 Market Overview
3.2 Growth Drivers
3.3 Restraints
3.4 Opportunities
Chapter 04 Deployment Model Insights
4.1 Cloud-Based
4.2 On-Premise
4.3 Hybrid
4.4 Software as a Service
4.5 Others
Chapter 05 Application Insights
5.1 Fetal Monitoring Analytics
5.2 Labor and Delivery Documentation
5.3 Neonatal Care Informatics
5.4 Postpartum Risk Monitoring
5.5 Others
Chapter 06 End User Insights
6.1 Hospitals
6.2 Ambulatory Birth Centers
6.3 Maternity Clinics
6.4 Medicaid Managed Care Plans
6.5 Others
Chapter 07 Competitive Landscape
7.1 Market Players
7.2 Leading Market Participants
7.2.1 GE HealthCare
7.2.2 Philips
7.2.3 Epic Systems
7.2.4 Oracle Health
7.2.5 Natus Medical
7.2.6 Mindray
7.2.7 Hologic
7.2.8 Masimo
7.2.9 Medtronic
7.2.10 Dräger
7.3 Regulatory Environment
7.4 Outlook

Research Framework and Methodological Approach

Information
Procurement

Information
Analysis

Market Formulation
& Validation

Overview of Our Research Process

MarketsNXT follows a structured, multi-stage research framework designed to ensure accuracy, reliability, and strategic relevance of every published study. Our methodology integrates globally accepted research standards with industry best practices in data collection, modeling, verification, and insight generation.

1. Data Acquisition Strategy

Robust data collection is the foundation of our analytical process. MarketsNXT employs a layered sourcing model.

Secondary Research
  • Company annual reports & SEC filings
  • Industry association publications
  • Technical journals & white papers
  • Government databases (World Bank, OECD)
  • Paid commercial databases
Primary Research
  • KOL Interviews (CEOs, Marketing Heads)
  • Surveys with industry participants
  • Distributor & supplier discussions
  • End-user feedback loops
  • Questionnaires for gap analysis

Analytical Modeling and Insight Development

After collection, datasets are processed and interpreted using multiple analytical techniques to identify baseline market values, demand patterns, growth drivers, constraints, and opportunity clusters.

2. Market Estimation Techniques

MarketsNXT applies multiple estimation pathways to strengthen forecast accuracy.

Bottom-up Approach

Country Level Market Size
Regional Market Size
Global Market Size

Aggregating granular demand data from country level to derive global figures.

Top-down Approach

Parent Market Size
Target Market Share
Segmented Market Size

Breaking down the parent industry market to identify the target serviceable market.

Supply Chain Anchored Forecasting

MarketsNXT integrates value chain intelligence into its forecasting structure to ensure commercial realism and operational alignment.

Supply-Side Evaluation

Revenue and capacity estimates are developed through company financial reviews, product portfolio mapping, benchmarking of competitive positioning, and commercialization tracking.

3. Market Engineering & Validation

Market engineering involves the triangulation of data from multiple sources to minimize errors.

01 Data Mining

Extensive gathering of raw data.

02 Analysis

Statistical regression & trend analysis.

03 Validation

Cross-verification with experts.

04 Final Output

Publication of market study.

Client-Centric Research Delivery

MarketsNXT positions research delivery as a collaborative engagement rather than a static information transfer. Analysts work with clients to clarify objectives, interpret findings, and connect insights to strategic decisions.